Lidocaine Accord

Lidocaine, the active ingredient in Lidocaine Accord, is a local anesthetic presented as a sterile injectable solution for epidural, intramuscular and intravenous use. It provides rapid, reversible loss of sensation for surgical anesthesia and acute pain management in adult patients under controlled clinical conditions.

GNH USA supplies Lidocaine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for import and distribution. Customers benefit from reliable logistics, batch traceability, and responsive technical assistance.

Lidocaine is a local anesthetic that blocks nerve conduction, making it suitable for several procedural and pain‑related applications.

Surgical anesthesia: Provides rapid, reversible loss of sensation for minor to major operative procedures. Obstetric/gynecologic epidural anesthesia: Enables safe pain control during labor and delivery. Acute pain management: Reduces pain intensity in postoperative or trauma‑related settings.

Lidocaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site - Light‑headedness or dizziness - Nausea or metallic taste

Serious or Rare Side Effects: - Seizures or central nervous system toxicity - Cardiac arrhythmias, including ventricular tachycardia - Methemoglobinemia or severe allergic reactions - Respiratory depression or hypotension

When using Lidocaine Accord, clinicians should observe several safety considerations to minimize risk.

Assess cardiac history: Evaluate for conduction abnormalities or recent myocardial infarction. Monitor for CNS toxicity: Observe for signs of dizziness, tinnitus, or seizures during infusion. Use caution in hepatic impairment: Adjust dosing in patients with reduced liver function. Avoid in patients with known lidocaine hypersensitivity: Discontinue immediately if allergic reaction occurs. Adjust dose in elderly or low‑body‑weight patients: Reduce initial dose and titrate carefully. Store at room temperature: Keep in original container, protect from moisture and light.

Lidocaine can interact with other medicines, altering its plasma concentration or enhancing toxicity.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): May increase risk of cardiac arrhythmias. - CYP3A4 inhibitors (e.g., amiodarone, cimetidine): Can raise lidocaine levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Other CNS depressants (e.g., benzodiazepines, opioids): May potentiate central nervous system effects. - Beta‑adrenergic blockers (e.g., propranolol): Can enhance lidocaine’s negative inotropic effect. - Diuretics (e.g., furosemide): May reduce plasma protein binding, increasing free lidocaine.